US Patent 7981605 Epidermal growth factor receptor mutations
Patent 7981605 was granted and assigned to Amgen on July, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 23, 2006
Date of Patent
July 19, 2011
Patent Application Number
11361711
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7981605 Epidermal growth factor receptor mutations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.